TLDR
- Loop Capital launched coverage of Astera Labs with a Buy recommendation and $250 price objective, suggesting approximately 110% potential upside from the previous closing price.
- The investment firm described ALAB as the most direct “pure play” on AI silicon beyond Nvidia.
- Astera Labs exceeded Q4 projections with earnings per share of $0.58 versus the anticipated $0.51, while revenue reached $270.6M — representing 91.8% growth year-over-year.
- Company insiders have divested 216,792 shares valued at $26.8M during the past 90 days, although insiders maintain ownership of 12.5% of outstanding shares.
- Loop Capital emphasized ALAB’s COSMOS software platform as a prospective industry benchmark with “moat-like stickiness.”
Astera Labs gained a fresh bullish voice on Thursday as Loop Capital launched coverage with a Buy recommendation and established a $250 price objective.
Astera Labs, Inc. Common Stock, ALAB
This price objective suggests approximately 110% upside potential from the stock’s most recent closing level. ALAB began trading at $119.00 on Thursday, significantly beneath its 52-week peak of $262.90.
Loop Capital analyst Ananda Baruah characterized Astera Labs as the firm “most representing a diversified AI silicon pure play” aside from Nvidia.
The investment rationale is clear: as artificial intelligence infrastructure expands and grows more sophisticated, the connectivity products ALAB manufactures become increasingly difficult to substitute.
Loop Capital observed that ALAB maintains exposure throughout “essentially all Gen AI silicon flavors” — including GPUs, Trainium, TPUs, and additional accelerators. Such diversity is uncommon among semiconductor companies.
The investment firm also highlighted Astera Labs’ COSMOS software and management platform as a prospective long-term competitive advantage. Baruah suggested it “could become industry standard,” establishing what he characterized as “moat-like stickiness” among clients.
Strong Recent Earnings
The coverage launch follows a robust Q4 earnings report. Astera Labs delivered EPS of $0.58 for the quarter, surpassing the $0.51 consensus projection by $0.07.
Revenue totaled $270.6M, exceeding the $249.5M estimate and climbing 91.8% compared to the identical quarter last year.
The company issued Q1 2026 EPS guidance ranging from $0.530 to $0.540. Wall Street analysts collectively project full-year EPS of $0.34.
Insider Selling Worth Watching
Not all signals are uniformly positive. Company insiders have been notably active as sellers during the previous 90 days.
General Counsel Philip Mazzara divested 10,000 shares on March 2nd at an average price of $117.47, representing a 7.24% decrease in his holdings.
COO Sanjay Gajendra offloaded 94,971 shares on February 17th at an average price of $123.81, reducing his position by 5.84%.
Collectively, insiders have sold 216,792 shares valued at roughly $26.8M during the last 90 days. Insiders continue to control 12.5% of the company.
Regarding Wall Street coverage, sentiment is varied but tilts favorable. Among 22 analysts monitored by MarketBeat, 15 maintain Buy ratings, six hold Hold ratings, and one has assigned a Sell.
The consensus price target stands at $195.89. Barclays maintains the Street’s lowest target at $165.00, established in January.
The shares trade at a P/E ratio of 97.54 with a market capitalization of $20.26 billion. The 50-day moving average sits at $154.84, while the 200-day average rests at $170.88 — both considerably above the present price.
Astera Labs has a 52-week low of $47.13.





